Papyrus Australia Secures AU$500,000 Funding to Accelerate Commercialisation and Scale-Up
Papyrus Australia Limited (ASX: PPY) has secured additional funding through four unsecured loan agreements with professional and sophisticated investors, providing aggregate facilities of up to AU$500,000. Each lender has committed up to AU$125,000, with interest accruing at 1.5% per month. Subject to shareholder approval, outstanding loans and accrued interest will convert into Tranche 2 Unsecured Convertible Notes.
The funding will support PPY’s commercialisation initiatives, working capital requirements, and delivery of its contract with TBS Mining Solutions for manufacturing and supplying a biodegradable variant of patented Collar Keeper® products. This additional capital is expected to strengthen operational capacity and facilitate planned scale-up activities.
PPY plans to seek shareholder approval at its 2026 Annual General Meeting for up to 535,000 convertible notes and 8,333,333 broker options for L39 Capital. The proposed notes carry a 1.0% monthly interest rate and a two-year maturity, providing PPY with financing flexibility while supporting its commercial expansion strategy.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Papyrus Australia Secures AU$500,000 Funding to Accelerate Commercialisation and Scale-Up
Papyrus Australia Limited (ASX: PPY) has secured additional funding through four unsecured loan agreements with professional and sophisticated investors, providing aggregate facilities of up to AU$500,000. Each lender has committed up to AU$125,000, with interest accruing at 1.5% per month. Subject to shareholder approval, outstanding loans and accrued interest will convert into Tranche 2 Unsecured Convertible Notes.
The funding will support PPY’s commercialisation initiatives, working capital requirements, and delivery of its contract with TBS Mining Solutions for manufacturing and supplying a biodegradable variant of patented Collar Keeper® products. This additional capital is expected to strengthen operational capacity and facilitate planned scale-up activities.
PPY plans to seek shareholder approval at its 2026 Annual General Meeting for up to 535,000 convertible notes and 8,333,333 broker options for L39 Capital. The proposed notes carry a 1.0% monthly interest rate and a two-year maturity, providing PPY with financing flexibility while supporting its commercial expansion strategy.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au